MaxCyte Appoints Douglas Swirsky As Chief Financial Officer
MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)))), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based